Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Myriad Genetics (GB:0K3W)
LSE:0K3W
Myriad Genetics (0K3W) Share Price & Analysis
0 Followers
0K3W Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.03 - $27.75
Previous Close$23.1
Volume20.00
Average Volume (3M)233.00
Market Cap
$1.90B
Enterprise Value$1.98B
Total Cash (Recent Filing)$78.70M
Total Debt (Recent Filing)$161.60M
Price to Earnings (P/E)-12.8
Beta0.14
Next Earnings
Aug 03, 2023EPS Estimate
-$0.08Last Dividend Ex-Date
Jun 15, 2009Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding81,555,161
10 Day Avg. Volume10
30 Day Avg. Volume233
Standard Deviation0.18
R-Squared0.17
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)10.89
Price to Sales (P/S)12.32
Price to Cash Flow (P/CF)-14.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.85
Enterprise Value/Gross Profit4.16
Enterprise Value/Ebitda-19.68
Forecast
1Y Price Target
$26.50Price Target Upside14.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Myriad Genetics News
0K3W FAQ
What was Myriad Genetics’s price range in the past 12 months?
Myriad Genetics lowest share price was $14.03 and its highest was $27.75 in the past 12 months.
What is Myriad Genetics’s market cap?
Currently, no data Available
When is Myriad Genetics’s upcoming earnings report date?
Myriad Genetics’s upcoming earnings report date is Aug 03, 2023 which is in 54 days.
How were Myriad Genetics’s earnings last quarter?
Myriad Genetics released its earnings results on May 03, 2023. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.193 by -$0.017.
Is Myriad Genetics overvalued?
According to Wall Street analysts Myriad Genetics’s price is currently Undervalued.
Does Myriad Genetics pay dividends?
Myriad Genetics pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Myriad Genetics dividends here
What is Myriad Genetics’s EPS estimate?
Myriad Genetics’s EPS estimate is -$0.08.
How many shares outstanding does Myriad Genetics have?
Myriad Genetics has 81,555,160 shares outstanding.
What happened to Myriad Genetics’s price movement after its last earnings report?
Myriad Genetics reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.193. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Myriad Genetics?
Among the largest hedge funds holding Myriad Genetics’s share is Glenview Capital Management LLC. It holds Myriad Genetics’s shares valued at 97M.
---
Myriad Genetics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.50 (14.70% Upside)
$26.50 (14.70% Upside)
Blogger Sentiment
Neutral
GB:0K3W Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.55%
12-Months-Change
Fundamentals
Return on Equity
-16.38%
Trailing 12-Months
Asset Growth
-6.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Myriad Genetics
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
---
---